世界の転移性膵がん治療市場規模・現状・予測（2021年-2027年）

• 英文タイトル：Global Metastatic Pancreatic Cancer Treatment Market Size, Status and Forecast 2021-2027

• レポートコード：QFJ1-4499 • 出版社/出版日：QYResearch / 2021年6月 ※2024年版があります。お問い合わせください。 • レポート形態：英文、PDF、99ページ • 納品方法：Eメール（納期：3日） • 産業分類：医療

• 販売価格（消費税別）

Single User	￥585,000 (USD3,900)	▷ お問い合わせ
Multi User	￥877,500 (USD5,850)	▷ お問い合わせ

• ご注文方法：お問い合わせフォーム記入又はEメールでご連絡ください。
• お支払方法：銀行振込（納品後、ご請求書送付）

---

レポート概要

---

QYResearch社発行の本調査レポートでは、転移性膵がん治療の世界市場（2016年～2027年）を対象に調査し、市場動向、主要企業の市場シェア、種類別市場規模（化学療法、標的療法、その他）、用途別市場規模（外分泌、内分泌）、主要地域別市場規模（北米、アメリカ、欧州、アジア、日本、中国、韓国、インド、東南アジア、中南米、中東、アフリカ等）、企業情報などをまとめております。 ・市場概要 ・転移性膵がん治療の市場動向 ・企業の競争状況、市場シェア ・転移性膵がん治療の種類別市場規模と予測2016-2027（化学療法、標的療法、その他） ・転移性膵がん治療の用途別市場規模と予測2016-2027（外分泌、内分泌） ・転移性膵がん治療の北米市場規模2016-2027（アメリカ、カナダ） ・転移性膵がん治療の欧州市場規模2016-2027（ドイツ、フランス、イギリス等） ・転移性膵がん治療のアジア市場規模2016-2027（日本、中国、韓国、インド、東南アジア等） ・転移性膵がん治療の中南米市場規模2016-2027（メキシコ、ブラジル） ・転移性膵がん治療の中東・アフリカ市場規模2016-2027（トルコ、サウジアラビア等） ・主要企業情報（Lilly、Merck、Celgene、BioLineRx、AstraZeneca、Roche、Amgen、Pfizer、Nantkwest, Inc） ・結論

Metastatic pancreatic cancer treatment, when cancer spreads outside of the pancreas, surgery may or may not be recommended. It’s more common for oncologists to recommend systemic treatments (which can circulate throughout the entire body and destroy cancerous cells in multiple locations) for metastatic pancreatic cancer.

Market Analysis and Insights: Global Metastatic Pancreatic Cancer Treatment Market
The global Metastatic Pancreatic Cancer Treatment market size is projected to reach US$ XX million by 2027, from US$ XX million in 2020, at a CAGR of XX% during 2021-2027.
With industry-standard accuracy in analysis and high data integrity, the report makes a brilliant attempt to unveil key opportunities available in the global Metastatic Pancreatic Cancer Treatment market to help players in achieving a strong market position. Buyers of the report can access verified and reliable market forecasts, including those for the overall size of the global Metastatic Pancreatic Cancer Treatment market in terms of revenue.
On the whole, the report proves to be an effective tool that players can use to gain a competitive edge over their competitors and ensure lasting success in the global Metastatic Pancreatic Cancer Treatment market. All of the findings, data, and information provided in the report are validated and revalidated with the help of trustworthy sources. The analysts who have authored the report took a unique and industry-best research and analysis approach for an in-depth study of the global Metastatic Pancreatic Cancer Treatment market.

Global Metastatic Pancreatic Cancer Treatment Scope and Market Size
Metastatic Pancreatic Cancer Treatment market is segmented by company, region (country), by Type, and by Application. Players, stakeholders, and other participants in the global Metastatic Pancreatic Cancer Treatment market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on revenue and forecast by Type and by Application in terms of revenue and forecast for the period 2016-2027.

Segment by Type
Chemotherapy,
Targeted Therapy
Others

Segment by Application
Exocrine
Endocrine

By Region
North America
United States
Canada
Europe
Germany
France
U.K.
Italy
Russia
Nordic
Rest of Europe
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Rest of Asia
Latin America
Mexico
Brazil
Rest of Latin America
Middle East & Africa
Turkey
Saudi Arabia
UAE
Rest of MEA

By Company
Lilly
Merck
Celgene
BioLineRx
AstraZeneca
Roche
Amgen
Pfizer
Nantkwest, Inc

レポート目次

---

1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Metastatic Pancreatic Cancer Treatment Market Size Growth Rate by Type: 2016 VS 2021 VS 2027
1.2.2 Chemotherapy,
1.2.3 Targeted Therapy
1.2.4 Others
1.3 Market by Application
1.3.1 Global Metastatic Pancreatic Cancer Treatment Market Share by Application: 2016 VS 2021 VS 2027
1.3.2 Exocrine
1.3.3 Endocrine
1.4 Study Objectives
1.5 Years Considered

2 Global Growth Trends
2.1 Global Metastatic Pancreatic Cancer Treatment Market Perspective (2016-2027)
2.2 Metastatic Pancreatic Cancer Treatment Growth Trends by Regions
2.2.1 Metastatic Pancreatic Cancer Treatment Market Size by Regions: 2016 VS 2021 VS 2027
2.2.2 Metastatic Pancreatic Cancer Treatment Historic Market Share by Regions (2016-2021)
2.2.3 Metastatic Pancreatic Cancer Treatment Forecasted Market Size by Regions (2022-2027)
2.3 Metastatic Pancreatic Cancer Treatment Industry Dynamic
2.3.1 Metastatic Pancreatic Cancer Treatment Market Trends
2.3.2 Metastatic Pancreatic Cancer Treatment Market Drivers
2.3.3 Metastatic Pancreatic Cancer Treatment Market Challenges
2.3.4 Metastatic Pancreatic Cancer Treatment Market Restraints

3 Competition Landscape by Key Players
3.1 Global Top Metastatic Pancreatic Cancer Treatment Players by Revenue
3.1.1 Global Top Metastatic Pancreatic Cancer Treatment Players by Revenue (2016-2021)
3.1.2 Global Metastatic Pancreatic Cancer Treatment Revenue Market Share by Players (2016-2021)
3.2 Global Metastatic Pancreatic Cancer Treatment Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
3.3 Players Covered: Ranking by Metastatic Pancreatic Cancer Treatment Revenue
3.4 Global Metastatic Pancreatic Cancer Treatment Market Concentration Ratio
3.4.1 Global Metastatic Pancreatic Cancer Treatment Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Metastatic Pancreatic Cancer Treatment Revenue in 2020
3.5 Metastatic Pancreatic Cancer Treatment Key Players Head office and Area Served
3.6 Key Players Metastatic Pancreatic Cancer Treatment Product Solution and Service
3.7 Date of Enter into Metastatic Pancreatic Cancer Treatment Market
3.8 Mergers & Acquisitions, Expansion Plans

4 Metastatic Pancreatic Cancer Treatment Breakdown Data by Type
4.1 Global Metastatic Pancreatic Cancer Treatment Historic Market Size by Type (2016-2021)
4.2 Global Metastatic Pancreatic Cancer Treatment Forecasted Market Size by Type (2022-2027)

5 Metastatic Pancreatic Cancer Treatment Breakdown Data by Application
5.1 Global Metastatic Pancreatic Cancer Treatment Historic Market Size by Application (2016-2021)
5.2 Global Metastatic Pancreatic Cancer Treatment Forecasted Market Size by Application (2022-2027)

6 North America
6.1 North America Metastatic Pancreatic Cancer Treatment Market Size (2016-2027)
6.2 North America Metastatic Pancreatic Cancer Treatment Market Size by Type
6.2.1 North America Metastatic Pancreatic Cancer Treatment Market Size by Type (2016-2021)
6.2.2 North America Metastatic Pancreatic Cancer Treatment Market Size by Type (2022-2027)
6.2.3 North America Metastatic Pancreatic Cancer Treatment Market Size by Type (2016-2027)
6.3 North America Metastatic Pancreatic Cancer Treatment Market Size by Application
6.3.1 North America Metastatic Pancreatic Cancer Treatment Market Size by Application (2016-2021)
6.3.2 North America Metastatic Pancreatic Cancer Treatment Market Size by Application (2022-2027)
6.3.3 North America Metastatic Pancreatic Cancer Treatment Market Size by Application (2016-2027)
6.4 North America Metastatic Pancreatic Cancer Treatment Market Size by Country
6.4.1 North America Metastatic Pancreatic Cancer Treatment Market Size by Country (2016-2021)
6.4.2 North America Metastatic Pancreatic Cancer Treatment Market Size by Country (2022-2027)
6.4.3 United States
6.4.4 Canada

7 Europe
7.1 Europe Metastatic Pancreatic Cancer Treatment Market Size (2016-2027)
7.2 Europe Metastatic Pancreatic Cancer Treatment Market Size by Type
7.2.1 Europe Metastatic Pancreatic Cancer Treatment Market Size by Type (2016-2021)
7.2.2 Europe Metastatic Pancreatic Cancer Treatment Market Size by Type (2022-2027)
7.2.3 Europe Metastatic Pancreatic Cancer Treatment Market Size by Type (2016-2027)
7.3 Europe Metastatic Pancreatic Cancer Treatment Market Size by Application
7.3.1 Europe Metastatic Pancreatic Cancer Treatment Market Size by Application (2016-2021)
7.3.2 Europe Metastatic Pancreatic Cancer Treatment Market Size by Application (2022-2027)
7.3.3 Europe Metastatic Pancreatic Cancer Treatment Market Size by Application (2016-2027)
7.4 Europe Metastatic Pancreatic Cancer Treatment Market Size by Country
7.4.1 Europe Metastatic Pancreatic Cancer Treatment Market Size by Country (2016-2021)
7.4.2 Europe Metastatic Pancreatic Cancer Treatment Market Size by Country (2022-2027)
7.4.3 Germany
7.4.4 France
7.4.5 U.K.
7.4.6 Italy
7.4.7 Russia
7.4.8 Nordic

8 Asia-Pacific
8.1 Asia-Pacific Metastatic Pancreatic Cancer Treatment Market Size (2016-2027)
8.2 Asia-Pacific Metastatic Pancreatic Cancer Treatment Market Size by Type
8.2.1 Asia-Pacific Metastatic Pancreatic Cancer Treatment Market Size by Type (2016-2021)
8.2.2 Asia-Pacific Metastatic Pancreatic Cancer Treatment Market Size by Type (2022-2027)
8.2.3 Asia-Pacific Metastatic Pancreatic Cancer Treatment Market Size by Type (2016-2027)
8.3 Asia-Pacific Metastatic Pancreatic Cancer Treatment Market Size by Application
8.3.1 Asia-Pacific Metastatic Pancreatic Cancer Treatment Market Size by Application (2016-2021)
8.3.2 Asia-Pacific Metastatic Pancreatic Cancer Treatment Market Size by Application (2022-2027)
8.3.3 Asia-Pacific Metastatic Pancreatic Cancer Treatment Market Size by Application (2016-2027)
8.4 Asia-Pacific Metastatic Pancreatic Cancer Treatment Market Size by Region
8.4.1 Asia-Pacific Metastatic Pancreatic Cancer Treatment Market Size by Region (2016-2021)
8.4.2 Asia-Pacific Metastatic Pancreatic Cancer Treatment Market Size by Region (2022-2027)
8.4.3 China
8.4.4 Japan
8.4.5 South Korea
8.4.6 Southeast Asia
8.4.7 India
8.4.8 Australia

9 Latin America
9.1 Latin America Metastatic Pancreatic Cancer Treatment Market Size (2016-2027)
9.2 Latin America Metastatic Pancreatic Cancer Treatment Market Size by Type
9.2.1 Latin America Metastatic Pancreatic Cancer Treatment Market Size by Type (2016-2021)
9.2.2 Latin America Metastatic Pancreatic Cancer Treatment Market Size by Type (2022-2027)
9.2.3 Latin America Metastatic Pancreatic Cancer Treatment Market Size by Type (2016-2027)
9.3 Latin America Metastatic Pancreatic Cancer Treatment Market Size by Application
9.3.1 Latin America Metastatic Pancreatic Cancer Treatment Market Size by Application (2016-2021)
9.3.2 Latin America Metastatic Pancreatic Cancer Treatment Market Size by Application (2022-2027)
9.3.3 Latin America Metastatic Pancreatic Cancer Treatment Market Size by Application (2016-2027)
9.4 Latin America Metastatic Pancreatic Cancer Treatment Market Size by Country
9.4.1 Latin America Metastatic Pancreatic Cancer Treatment Market Size by Country (2016-2021)
9.4.2 Latin America Metastatic Pancreatic Cancer Treatment Market Size by Country (2022-2027)
9.4.3 Mexico
9.4.4 Brazil

10 Middle East & Africa
10.1 Middle East & Africa Metastatic Pancreatic Cancer Treatment Market Size (2016-2027)
10.2 Middle East & Africa Metastatic Pancreatic Cancer Treatment Market Size by Type
10.2.1 Middle East & Africa Metastatic Pancreatic Cancer Treatment Market Size by Type (2016-2021)
10.2.2 Middle East & Africa Metastatic Pancreatic Cancer Treatment Market Size by Type (2022-2027)
10.2.3 Middle East & Africa Metastatic Pancreatic Cancer Treatment Market Size by Type (2016-2027)
10.3 Middle East & Africa Metastatic Pancreatic Cancer Treatment Market Size by Application
10.3.1 Middle East & Africa Metastatic Pancreatic Cancer Treatment Market Size by Application (2016-2021)
10.3.2 Middle East & Africa Metastatic Pancreatic Cancer Treatment Market Size by Application (2022-2027)
10.3.3 Middle East & Africa Metastatic Pancreatic Cancer Treatment Market Size by Application (2016-2027)
10.4 Middle East & Africa Metastatic Pancreatic Cancer Treatment Market Size by Country
10.4.1 Middle East & Africa Metastatic Pancreatic Cancer Treatment Market Size by Country (2016-2021)
10.4.2 Middle East & Africa Metastatic Pancreatic Cancer Treatment Market Size by Country (2022-2027)
10.4.3 Turkey
10.4.4 Saudi Arabia
10.4.5 UAE

11 Key Players Profiles
11.1 Lilly
11.1.1 Lilly Company Details
11.1.2 Lilly Business Overview
11.1.3 Lilly Metastatic Pancreatic Cancer Treatment Introduction
11.1.4 Lilly Revenue in Metastatic Pancreatic Cancer Treatment Business (2016-2021)
11.1.5 Lilly Recent Development
11.2 Merck
11.2.1 Merck Company Details
11.2.2 Merck Business Overview
11.2.3 Merck Metastatic Pancreatic Cancer Treatment Introduction
11.2.4 Merck Revenue in Metastatic Pancreatic Cancer Treatment Business (2016-2021)
11.2.5 Merck Recent Development
11.3 Celgene
11.3.1 Celgene Company Details
11.3.2 Celgene Business Overview
11.3.3 Celgene Metastatic Pancreatic Cancer Treatment Introduction
11.3.4 Celgene Revenue in Metastatic Pancreatic Cancer Treatment Business (2016-2021)
11.3.5 Celgene Recent Development
11.4 BioLineRx
11.4.1 BioLineRx Company Details
11.4.2 BioLineRx Business Overview
11.4.3 BioLineRx Metastatic Pancreatic Cancer Treatment Introduction
11.4.4 BioLineRx Revenue in Metastatic Pancreatic Cancer Treatment Business (2016-2021)
11.4.5 BioLineRx Recent Development
11.5 AstraZeneca
11.5.1 AstraZeneca Company Details
11.5.2 AstraZeneca Business Overview
11.5.3 AstraZeneca Metastatic Pancreatic Cancer Treatment Introduction
11.5.4 AstraZeneca Revenue in Metastatic Pancreatic Cancer Treatment Business (2016-2021)
11.5.5 AstraZeneca Recent Development
11.6 Roche
11.6.1 Roche Company Details
11.6.2 Roche Business Overview
11.6.3 Roche Metastatic Pancreatic Cancer Treatment Introduction
11.6.4 Roche Revenue in Metastatic Pancreatic Cancer Treatment Business (2016-2021)
11.6.5 Roche Recent Development
11.7 Amgen
11.7.1 Amgen Company Details
11.7.2 Amgen Business Overview
11.7.3 Amgen Metastatic Pancreatic Cancer Treatment Introduction
11.7.4 Amgen Revenue in Metastatic Pancreatic Cancer Treatment Business (2016-2021)
11.7.5 Amgen Recent Development
11.8 Pfizer
11.8.1 Pfizer Company Details
11.8.2 Pfizer Business Overview
11.8.3 Pfizer Metastatic Pancreatic Cancer Treatment Introduction
11.8.4 Pfizer Revenue in Metastatic Pancreatic Cancer Treatment Business (2016-2021)
11.8.5 Pfizer Recent Development
11.9 Nantkwest, Inc
11.9.1 Nantkwest, Inc Company Details
11.9.2 Nantkwest, Inc Business Overview
11.9.3 Nantkwest, Inc Metastatic Pancreatic Cancer Treatment Introduction
11.9.4 Nantkwest, Inc Revenue in Metastatic Pancreatic Cancer Treatment Business (2016-2021)
11.9.5 Nantkwest, Inc Recent Development

12 Analyst’s Viewpoints/Conclusions

13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.2 Data Source
13.2 Disclaimer
13.3 Author Details

List of Tables
Table 1. Global Metastatic Pancreatic Cancer Treatment Market Size Growth Rate by Type (US$ Million):2016 VS 2021 VS 2027
Table 2. Key Players of Chemotherapy,
Table 3. Key Players of Targeted Therapy
Table 4. Key Players of Others
Table 5. Global Metastatic Pancreatic Cancer Treatment Market Size Growth by Application (US$ Million): 2016 VS 2021 VS 2027
Table 6. Global Metastatic Pancreatic Cancer Treatment Market Size by Regions (US$ Million): 2016 VS 2021 VS 2027
Table 7. Global Metastatic Pancreatic Cancer Treatment Market Size by Regions (2016-2021) & (US$ Million)
Table 8. Global Metastatic Pancreatic Cancer Treatment Market Share by Regions (2016-2021)
Table 9. Global Metastatic Pancreatic Cancer Treatment Forecasted Market Size by Regions (2022-2027) & (US$ Million)
Table 10. Global Metastatic Pancreatic Cancer Treatment Market Share by Regions (2022-2027)
Table 11. Metastatic Pancreatic Cancer Treatment Market Trends
Table 12. Metastatic Pancreatic Cancer Treatment Market Drivers
Table 13. Metastatic Pancreatic Cancer Treatment Market Challenges
Table 14. Metastatic Pancreatic Cancer Treatment Market Restraints
Table 15. Global Metastatic Pancreatic Cancer Treatment Revenue by Players (2016-2021) & (US$ Million)
Table 16. Global Metastatic Pancreatic Cancer Treatment Market Share by Players (2016-2021)
Table 17. Global Top Metastatic Pancreatic Cancer Treatment Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Metastatic Pancreatic Cancer Treatment as of 2020)
Table 18. Ranking of Global Top Metastatic Pancreatic Cancer Treatment Companies by Revenue (US$ Million) in 2020
Table 19. Global 5 Largest Players Market Share by Metastatic Pancreatic Cancer Treatment Revenue (CR5 and HHI) & (2016-2021)
Table 20. Key Players Headquarters and Area Served
Table 21. Key Players Metastatic Pancreatic Cancer Treatment Product Solution and Service
Table 22. Date of Enter into Metastatic Pancreatic Cancer Treatment Market
Table 23. Mergers & Acquisitions, Expansion Plans
Table 24. Global Metastatic Pancreatic Cancer Treatment Market Size by Type (2016-2021) (US$ Million)
Table 25. Global Metastatic Pancreatic Cancer Treatment Revenue Market Share by Type (2016-2021)
Table 26. Global Metastatic Pancreatic Cancer Treatment Forecasted Market Size by Type (2022-2027) (US$ Million)
Table 27. Global Metastatic Pancreatic Cancer Treatment Revenue Market Share by Type (2022-2027) & (US$ Million)
Table 28. Global Metastatic Pancreatic Cancer Treatment Market Size Share by Application (2016-2021) & (US$ Million)
Table 29. Global Metastatic Pancreatic Cancer Treatment Revenue Market Share by Application (2016-2021)
Table 30. Global Metastatic Pancreatic Cancer Treatment Forecasted Market Size by Application (2022-2027) (US$ Million)
Table 31. Global Metastatic Pancreatic Cancer Treatment Revenue Market Share by Application (2022-2027) & (US$ Million)
Table 32. North America Metastatic Pancreatic Cancer Treatment Market Size by Type (2016-2021) (US$ Million)
Table 33. North America Metastatic Pancreatic Cancer Treatment Market Size by Type (2022-2027) & (US$ Million)
Table 34. North America Metastatic Pancreatic Cancer Treatment Market Size by Application (2016-2021) (US$ Million)
Table 35. North America Metastatic Pancreatic Cancer Treatment Market Size by Application (2022-2027) & (US$ Million)
Table 36. North America Metastatic Pancreatic Cancer Treatment Market Size by Country (2016-2021) & (US$ Million)
Table 37. North America Metastatic Pancreatic Cancer Treatment Market Size by Country (2022-2027) & (US$ Million)
Table 38. Europe Metastatic Pancreatic Cancer Treatment Market Size by Type (2016-2021) (US$ Million)
Table 39. Europe Metastatic Pancreatic Cancer Treatment Market Size by Type (2022-2027) & (US$ Million)
Table 40. Europe Metastatic Pancreatic Cancer Treatment Market Size by Application (2016-2021) (US$ Million)
Table 41. Europe Metastatic Pancreatic Cancer Treatment Market Size by Application (2022-2027) & (US$ Million)
Table 42. Europe Metastatic Pancreatic Cancer Treatment Market Size by Country (2016-2021) & (US$ Million)
Table 43. Europe Metastatic Pancreatic Cancer Treatment Market Size by Country (2022-2027) & (US$ Million)
Table 44. Asia-Pacific Metastatic Pancreatic Cancer Treatment Market Size by Type (2016-2021) (US$ Million)
Table 45. Asia-Pacific Metastatic Pancreatic Cancer Treatment Market Size by Type (2022-2027) & (US$ Million)
Table 46. Asia-Pacific Metastatic Pancreatic Cancer Treatment Market Size by Application (2016-2021) (US$ Million)
Table 47. Asia-Pacific Metastatic Pancreatic Cancer Treatment Market Size by Application (2022-2027) & (US$ Million)
Table 48. Asia-Pacific Metastatic Pancreatic Cancer Treatment Market Size by Region (2016-2021) & (US$ Million)
Table 49. Asia-Pacific Metastatic Pancreatic Cancer Treatment Market Size by Region (2022-2027) & (US$ Million)
Table 50. Latin America Metastatic Pancreatic Cancer Treatment Market Size by Type (2016-2021) (US$ Million)
Table 51. Latin America Metastatic Pancreatic Cancer Treatment Market Size by Type (2022-2027) & (US$ Million)
Table 52. Latin America Metastatic Pancreatic Cancer Treatment Market Size by Application (2016-2021) (US$ Million)
Table 53. Latin America Metastatic Pancreatic Cancer Treatment Market Size by Application (2022-2027) & (US$ Million)
Table 54. Latin America Metastatic Pancreatic Cancer Treatment Market Size by Country (2016-2021) & (US$ Million)
Table 55. Latin America Metastatic Pancreatic Cancer Treatment Market Size by Country (2022-2027) & (US$ Million)
Table 56. Middle East & Africa Metastatic Pancreatic Cancer Treatment Market Size by Type (2016-2021) (US$ Million)
Table 57. Middle East & Africa Metastatic Pancreatic Cancer Treatment Market Size by Type (2022-2027) & (US$ Million)
Table 58. Middle East & Africa Metastatic Pancreatic Cancer Treatment Market Size by Application (2016-2021) (US$ Million)
Table 59. Middle East & Africa Metastatic Pancreatic Cancer Treatment Market Size by Application (2022-2027) & (US$ Million)
Table 60. Middle East & Africa Metastatic Pancreatic Cancer Treatment Market Size by Country (2016-2021) & (US$ Million)
Table 61. Middle East & Africa Metastatic Pancreatic Cancer Treatment Market Size by Country (2022-2027) & (US$ Million)
Table 62. Lilly Company Details
Table 63. Lilly Business Overview
Table 64. Lilly Metastatic Pancreatic Cancer Treatment Product
Table 65. Lilly Revenue in Metastatic Pancreatic Cancer Treatment Business (2016-2021) & (US$ Million)
Table 66. Lilly Recent Development
Table 67. Merck Company Details
Table 68. Merck Business Overview
Table 69. Merck Metastatic Pancreatic Cancer Treatment Product
Table 70. Merck Revenue in Metastatic Pancreatic Cancer Treatment Business (2016-2021) & (US$ Million)
Table 71. Merck Recent Development
Table 72. Celgene Company Details
Table 73. Celgene Business Overview
Table 74. Celgene Metastatic Pancreatic Cancer Treatment Product
Table 75. Celgene Revenue in Metastatic Pancreatic Cancer Treatment Business (2016-2021) & (US$ Million)
Table 76. Celgene Recent Development
Table 77. BioLineRx Company Details
Table 78. BioLineRx Business Overview
Table 79. BioLineRx Metastatic Pancreatic Cancer Treatment Product
Table 80. BioLineRx Revenue in Metastatic Pancreatic Cancer Treatment Business (2016-2021) & (US$ Million)
Table 81. BioLineRx Recent Development
Table 82. AstraZeneca Company Details
Table 83. AstraZeneca Business Overview
Table 84. AstraZeneca Metastatic Pancreatic Cancer Treatment Product
Table 85. AstraZeneca Revenue in Metastatic Pancreatic Cancer Treatment Business (2016-2021) & (US$ Million)
Table 86. AstraZeneca Recent Development
Table 87. Roche Company Details
Table 88. Roche Business Overview
Table 89. Roche Metastatic Pancreatic Cancer Treatment Product
Table 90. Roche Revenue in Metastatic Pancreatic Cancer Treatment Business (2016-2021) & (US$ Million)
Table 91. Roche Recent Development
Table 92. Amgen Company Details
Table 93. Amgen Business Overview
Table 94. Amgen Metastatic Pancreatic Cancer Treatment Product
Table 95. Amgen Revenue in Metastatic Pancreatic Cancer Treatment Business (2016-2021) & (US$ Million)
Table 96. Amgen Recent Development
Table 97. Pfizer Company Details
Table 98. Pfizer Business Overview
Table 99. Pfizer Revenue in Metastatic Pancreatic Cancer Treatment Business (2016-2021) & (US$ Million)
Table 100. Pfizer Recent Development
Table 101. Nantkwest, Inc Company Details
Table 102. Nantkwest, Inc Business Overview
Table 103. Nantkwest, Inc Metastatic Pancreatic Cancer Treatment Product
Table 104. Nantkwest, Inc Revenue in Metastatic Pancreatic Cancer Treatment Business (2016-2021) & (US$ Million)
Table 105. Nantkwest, Inc Recent Development
Table 106. Research Programs/Design for This Report
Table 107. Key Data Information from Secondary Sources
Table 108. Key Data Information from Primary Sources
List of Figures
Figure 1. Global Metastatic Pancreatic Cancer Treatment Market Share by Type: 2020 VS 2027
Figure 2. Chemotherapy, Features
Figure 3. Targeted Therapy Features
Figure 4. Others Features
Figure 5. Global Metastatic Pancreatic Cancer Treatment Market Share by Application: 2020 VS 2027
Figure 6. Exocrine Case Studies
Figure 7. Endocrine Case Studies
Figure 8. Metastatic Pancreatic Cancer Treatment Report Years Considered
Figure 9. Global Metastatic Pancreatic Cancer Treatment Market Size (US$ Million), Year-over-Year: 2016-2027
Figure 10. Global Metastatic Pancreatic Cancer Treatment Market Size (US$ Million), 2016 VS 2021 VS 2027
Figure 11. Global Metastatic Pancreatic Cancer Treatment Market Share by Regions: 2020 VS 2027
Figure 12. Global Metastatic Pancreatic Cancer Treatment Market Share by Regions (2022-2027)
Figure 13. Global Metastatic Pancreatic Cancer Treatment Market Share by Players in 2020
Figure 14. Global Top Metastatic Pancreatic Cancer Treatment Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Metastatic Pancreatic Cancer Treatment as of 2020
Figure 15. The Top 10 and 5 Players Market Share by Metastatic Pancreatic Cancer Treatment Revenue in 2020
Figure 16. Global Metastatic Pancreatic Cancer Treatment Revenue Market Share by Type (2016-2021)
Figure 17. Global Metastatic Pancreatic Cancer Treatment Revenue Market Share by Type (2022-2027)
Figure 18. North America Metastatic Pancreatic Cancer Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 19. North America Metastatic Pancreatic Cancer Treatment Market Share by Type (2016-2027)
Figure 20. North America Metastatic Pancreatic Cancer Treatment Market Share by Application (2016-2027)
Figure 21. North America Metastatic Pancreatic Cancer Treatment Market Share by Country (2016-2027)
Figure 22. United States Metastatic Pancreatic Cancer Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 23. Canada Metastatic Pancreatic Cancer Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 24. Europe Metastatic Pancreatic Cancer Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 25. Europe Metastatic Pancreatic Cancer Treatment Market Share by Type (2016-2027)
Figure 26. Europe Metastatic Pancreatic Cancer Treatment Market Share by Application (2016-2027)
Figure 27. Europe Metastatic Pancreatic Cancer Treatment Market Share by Country (2016-2027)
Figure 28. Germany Metastatic Pancreatic Cancer Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 29. France Metastatic Pancreatic Cancer Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 30. U.K. Metastatic Pancreatic Cancer Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 31. Italy Metastatic Pancreatic Cancer Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 32. Russia Metastatic Pancreatic Cancer Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 33. Nordic Metastatic Pancreatic Cancer Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 34. Asia-Pacific Metastatic Pancreatic Cancer Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 35. Asia-Pacific Metastatic Pancreatic Cancer Treatment Market Share by Type (2016-2027)
Figure 36. Asia-Pacific Metastatic Pancreatic Cancer Treatment Market Share by Application (2016-2027)
Figure 37. Asia-Pacific Metastatic Pancreatic Cancer Treatment Market Share by Region (2016-2027)
Figure 38. China Metastatic Pancreatic Cancer Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 39. Japan Metastatic Pancreatic Cancer Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 40. South Korea Metastatic Pancreatic Cancer Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 41. Southeast Asia Metastatic Pancreatic Cancer Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 42. India Metastatic Pancreatic Cancer Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 43. Australia Metastatic Pancreatic Cancer Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 44. Latin America Metastatic Pancreatic Cancer Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 45. Latin America Metastatic Pancreatic Cancer Treatment Market Share by Type (2016-2027)
Figure 46. Latin America Metastatic Pancreatic Cancer Treatment Market Share by Application (2016-2027)
Figure 47. Latin America Metastatic Pancreatic Cancer Treatment Market Share by Country (2016-2027)
Figure 48. Mexico Metastatic Pancreatic Cancer Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 49. Brazil Metastatic Pancreatic Cancer Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 50. Middle East & Africa Metastatic Pancreatic Cancer Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 51. Middle East & Africa Metastatic Pancreatic Cancer Treatment Market Share by Type (2016-2027)
Figure 52. Middle East & Africa Metastatic Pancreatic Cancer Treatment Market Share by Application (2016-2027)
Figure 53. Middle East & Africa Metastatic Pancreatic Cancer Treatment Market Share by Country (2016-2027)
Figure 54. Turkey Metastatic Pancreatic Cancer Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 55. Saudi Arabia Metastatic Pancreatic Cancer Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 56. UAE Metastatic Pancreatic Cancer Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 57. Lilly Revenue Growth Rate in Metastatic Pancreatic Cancer Treatment Business (2016-2021)
Figure 58. Merck Revenue Growth Rate in Metastatic Pancreatic Cancer Treatment Business (2016-2021)
Figure 59. Celgene Revenue Growth Rate in Metastatic Pancreatic Cancer Treatment Business (2016-2021)
Figure 60. BioLineRx Revenue Growth Rate in Metastatic Pancreatic Cancer Treatment Business (2016-2021)
Figure 61. AstraZeneca Revenue Growth Rate in Metastatic Pancreatic Cancer Treatment Business (2016-2021)
Figure 62. Roche Revenue Growth Rate in Metastatic Pancreatic Cancer Treatment Business (2016-2021)
Figure 63. Amgen Revenue Growth Rate in Metastatic Pancreatic Cancer Treatment Business (2016-2021)
Figure 64. Pfizer Revenue Growth Rate in Metastatic Pancreatic Cancer Treatment Business (2016-2021)
Figure 65. Nantkwest, Inc Revenue Growth Rate in Metastatic Pancreatic Cancer Treatment Business (2016-2021)
Figure 66. Bottom-up and Top-down Approaches for This Report
Figure 67. Data Triangulation
Figure 68. Key Executives Interviewed

---